MPM BioVentures 2022, L.P. — Form D/A
MPM BioVentures 2022, L.P. of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-06-01. $351.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-06-01
- Form: D/A
- Accession: 0001921656-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $351.0M
- Investors: 45
- Date of first sale: 2022-05-26
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-444554
Issuer
- Name: MPM BioVentures 2022, L.P.
- CIK: 0001921656
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 399 BOYLSTON STREET, SUITE 1100, BOSTON, MA, 02116
- Phone: 617-425-9200
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Ansbert Gadicke | Executive Officer | Morristown, NJ |
| N/A MPM BIOVENTURES 2022 GP LLC | Promoter | BOSTON, MA |
| Luke Evnin | Executive Officer | Watertown, MA |
Other filings by this issuer (1)
More